{"transactions":[{"id":826281,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-03-27T23:34:29.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":12.88,"expiration_date":"2026-09-13","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001104659-26-036318","document":"tm2610129-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926036318/tm2610129-2_4seq1.xml","form_type":"4"}},{"id":826280,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-27T23:34:29.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":24000,"price":105,"value":2520000.0,"ownership":{"direct":true},"balance_after":60845,"source":{"system":"sec-edgar","filing":"0001104659-26-036318","document":"tm2610129-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926036318/tm2610129-2_4seq1.xml","form_type":"4"}},{"id":826279,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-27T23:34:29.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":24000,"price":12.88,"value":309120.0,"ownership":{"direct":true},"balance_after":84845,"source":{"system":"sec-edgar","filing":"0001104659-26-036318","document":"tm2610129-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926036318/tm2610129-2_4seq1.xml","form_type":"4"}},{"id":939993,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-13T21:45:36.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":false,"shares":14299,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.21,"expiration_date":"2026-04-29","underlying":"Common Stock","underlying_shares":14299},"source":{"system":"sec-edgar","filing":"0001104659-26-003386","document":"tm263110-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926003386/tm263110-1_4seq1.xml","form_type":"4"}},{"id":939992,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-13T21:45:36.000Z","date":"2026-01-09","kind":"exercise","planned":false,"acquired":true,"shares":14299,"price":4.21,"value":60198.79,"ownership":{"direct":true},"balance_after":60845,"source":{"system":"sec-edgar","filing":"0001104659-26-003386","document":"tm263110-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926003386/tm263110-1_4seq1.xml","form_type":"4"}},{"id":946159,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T00:44:13.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":3762,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 12 equal monthly installments following January 2, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":3762,"derivative":{"exercise_price":87.18,"expiration_date":"2036-01-02","underlying":"Common Stock","underlying_shares":3762},"source":{"system":"sec-edgar","filing":"0001104659-26-001479","document":"tm262304-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926001479/tm262304-8_4seq1.xml","form_type":"4"}},{"id":946158,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-07T00:44:13.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":2695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":46546,"source":{"system":"sec-edgar","filing":"0001104659-26-001479","document":"tm262304-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465926001479/tm262304-8_4seq1.xml","form_type":"4"}},{"id":1163318,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-04-30T20:45:59.000Z","date":"2025-04-28","kind":"exercise","planned":false,"acquired":false,"shares":10725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These stock options are fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.16,"expiration_date":"2025-10-28","underlying":"Common Stock","underlying_shares":10725},"source":{"system":"sec-edgar","filing":"0001104659-25-042608","document":"tm2513710-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925042608/tm2513710-1_4seq1.xml","form_type":"4"}},{"id":1163317,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-30T20:45:59.000Z","date":"2025-04-28","kind":"exercise","planned":false,"acquired":true,"shares":10725,"price":1.16,"value":12441.0,"ownership":{"direct":true},"balance_after":43851,"source":{"system":"sec-edgar","filing":"0001104659-25-042608","document":"tm2513710-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925042608/tm2513710-1_4seq1.xml","form_type":"4"}},{"id":1310230,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-06T23:08:38.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in 12 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":6584,"derivative":{"exercise_price":38.98,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":6584},"source":{"system":"sec-edgar","filing":"0001104659-25-001430","document":"tm252003-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925001430/tm252003-5_4seq1.xml","form_type":"4"}},{"id":1310229,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-06T23:08:38.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":5130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":33126,"source":{"system":"sec-edgar","filing":"0001104659-25-001430","document":"tm252003-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465925001430/tm252003-5_4seq1.xml","form_type":"4"}},{"id":1397825,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-09-30T17:36:35.000Z","date":"2024-09-27","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of September 27, 2024."}],"balance_after":1000,"derivative":{"exercise_price":1.41,"expiration_date":"2034-09-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0000950170-24-110457","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287233/000095017024110457/ownership.xml","form_type":"4"}},{"id":1583936,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-12T00:00:28.000Z","date":"2024-03-07","kind":"exercise","planned":false,"acquired":false,"shares":6490,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":1.89,"expiration_date":"2024-10-22","underlying":"Common Stock","underlying_shares":6490},"source":{"system":"sec-edgar","filing":"0001104659-24-033132","document":"tm248535-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465924033132/tm248535-1_4seq1.xml","form_type":"4"}},{"id":1583935,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T00:00:28.000Z","date":"2024-03-07","kind":"exercise","planned":false,"acquired":true,"shares":6490,"price":1.89,"value":12266.1,"ownership":{"direct":true},"balance_after":27996,"source":{"system":"sec-edgar","filing":"0001104659-24-033132","document":"tm248535-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465924033132/tm248535-1_4seq1.xml","form_type":"4"}},{"id":1687505,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-05T01:13:18.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":25700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date."}],"balance_after":25700,"derivative":{"exercise_price":23.42,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":25700},"source":{"system":"sec-edgar","filing":"0001104659-24-001493","document":"tm241954-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465924001493/tm241954-5_4seq1.xml","form_type":"4"}},{"id":1753093,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-10-31T18:46:44.000Z","date":"2023-10-27","kind":"grant","planned":false,"acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The figures reflected herein have been adjusted to take into account a 1 for 15 reverse split of the Company's common stock that was effected on August 11, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares of common stock exercisable pursuant to the option will vest in full upon completion of continuous service for the Issuer on the first anniversary of the vesting commencement date of October 27, 2023."}],"balance_after":1000,"derivative":{"exercise_price":6.06,"expiration_date":"2033-10-27","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001171843-23-006570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287233/000117184323006570/ownership.xml","form_type":"4"}},{"id":1921686,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-04-11T23:18:54.000Z","date":"2023-04-10","kind":"exercise","planned":false,"acquired":false,"shares":6196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option is vested in full."}],"balance_after":0,"derivative":{"exercise_price":0.87,"expiration_date":"2023-09-26","underlying":"Common Stock","underlying_shares":6196},"source":{"system":"sec-edgar","filing":"0001104659-23-044168","document":"tm2312473-1_4seq.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465923044168/tm2312473-1_4seq.xml","form_type":"4"}},{"id":1921685,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-11T23:18:54.000Z","date":"2023-04-10","kind":"exercise","planned":false,"acquired":true,"shares":6196,"price":0.87,"value":5390.52,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The shares of common stock reported on this Form 4 are subject to a lock-up agreement between the reporting person and J.P. Morgan Securities LLC, Jefferies LLC and Piper Sandler & Co., dated April 4, 2023 (the \"Lock-up Date\") pursuant to which the shares of common stock reported herein cannot be sold for 60 days following the Lock-up Date."}],"balance_after":21506,"source":{"system":"sec-edgar","filing":"0001104659-23-044168","document":"tm2312473-1_4seq.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465923044168/tm2312473-1_4seq.xml","form_type":"4"}},{"id":2052262,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-19T00:58:35.000Z","date":"2023-01-16","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in 12 equal monthly installments following the date of grant."}],"balance_after":30000,"derivative":{"exercise_price":12.17,"expiration_date":"2033-01-15","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-23-004731","document":"tm233829-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465923004731/tm233829-10_4seq1.xml","form_type":"4"}},{"id":2242096,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-06T07:30:12.000Z","date":"2022-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on June 3, 2023."}],"balance_after":15000,"derivative":{"exercise_price":0.9728,"expiration_date":"2032-06-02","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-22-021137","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287233/000089924322021137/doc4.xml","form_type":"4"}},{"id":2253117,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-27T20:00:57.000Z","date":"2022-05-26","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in full on the earlier of (i) May 26, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service with the Issuer through such date."}],"balance_after":20000,"derivative":{"exercise_price":8.31,"expiration_date":"2032-05-26","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-065860","document":"tm2214526-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000110465922065860/tm2214526-4_4seq1.xml","form_type":"4"}},{"id":2680739,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-04T16:30:35.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on June 3, 2022."}],"balance_after":15000,"derivative":{"exercise_price":8.98,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-21-022046","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287233/000089924321022046/doc4.xml","form_type":"4"}},{"id":2691048,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T23:00:57.000Z","date":"2021-05-27","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier of (i) May 27, 2022, or (ii) the date of the 2022 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":18000,"derivative":{"exercise_price":35.23,"expiration_date":"2031-05-26","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001209191-21-036667","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919121036667/doc4.xml","form_type":"4"}},{"id":3128917,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-01T17:09:43.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on May 28, 2021."}],"balance_after":15000,"derivative":{"exercise_price":15.43,"expiration_date":"2030-05-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-20-014741","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287233/000089924320014741/doc4.xml","form_type":"4"}},{"id":3130438,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-29T22:18:08.000Z","date":"2020-05-28","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier of (i) May 28, 2021, or (ii) the date of the 2021 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":15000,"derivative":{"exercise_price":16.54,"expiration_date":"2030-05-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-20-033026","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919120033026/doc4.xml","form_type":"4"}},{"id":3213365,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T23:26:50.000Z","date":"2020-03-12","kind":"purchase","acquired":true,"shares":12000,"price":6.7,"value":80400.0,"ownership":{"direct":true},"balance_after":15310,"source":{"system":"sec-edgar","filing":"0001209191-20-018645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919120018645/doc4.xml","form_type":"4"}},{"id":3480620,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-25T01:39:28.000Z","date":"2019-06-20","kind":"grant","acquired":true,"shares":126050,"price":3,"value":378150.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options shall vest on a monthly basis pro rata over the twelve (12) months following the grant date, provided that the recipient's continuous service has not terminated prior to the applicable vesting date."}],"balance_after":126050,"derivative":{"exercise_price":3,"expiration_date":"2029-06-19","underlying":"Common stock","underlying_shares":126050},"source":{"system":"sec-edgar","filing":"0000882104-19-000072","document":"wf-form4_156142675360674.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210419000072/wf-form4_156142675360674.xml","form_type":"4"}},{"id":3493947,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-11T22:29:24.000Z","date":"2019-06-07","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier of (i) June 7, 2020, or (ii) the date of the 2020 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":12000,"derivative":{"exercise_price":11.8,"expiration_date":"2029-06-06","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-036207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119036207/doc4.xml","form_type":"4"}},{"id":3507370,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-30T19:57:12.000Z","date":"2019-05-29","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on May 29, 2020."}],"balance_after":15000,"derivative":{"exercise_price":8.21,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-19-015226","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287233/000089924319015226/doc4.xml","form_type":"4"}},{"id":3568302,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-02T23:19:20.000Z","date":"2019-04-01","kind":"exercise","acquired":false,"shares":3310,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vested in 36 equal monthly installments following the vesting commencement date."}],"balance_after":0,"derivative":{"exercise_price":1.31,"expiration_date":"2019-05-14","underlying":"Common Stock","underlying_shares":3310},"source":{"system":"sec-edgar","filing":"0001209191-19-022784","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119022784/doc4.xml","form_type":"4"}},{"id":3568301,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-02T23:19:20.000Z","date":"2019-04-01","kind":"exercise","acquired":true,"shares":3310,"price":1.31,"value":4336.1,"ownership":{"direct":true},"balance_after":3310,"source":{"system":"sec-edgar","filing":"0001209191-19-022784","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919119022784/doc4.xml","form_type":"4"}},{"id":3896616,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-12T22:48:17.000Z","date":"2018-05-29","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier on (i) May 29, 2019, or (ii) the date of the 2019 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":12000,"derivative":{"exercise_price":6.98,"expiration_date":"2028-05-28","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-18-037313","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919118037313/doc4.xml","form_type":"4"}},{"id":3897535,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2018-06-12T20:28:08.000Z","date":"2018-06-08","kind":"grant","acquired":true,"shares":54348,"price":2.76,"value":150000.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc."}],"balance_after":256828,"source":{"system":"sec-edgar","filing":"0000882104-18-000063","document":"wf-form4_152883526808795.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210418000063/wf-form4_152883526808795.xml","form_type":"4"}},{"id":3908059,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T16:20:45.000Z","date":"2018-05-31","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the total number of shares subject to the option shall vest on May 31, 2019."}],"balance_after":15000,"derivative":{"exercise_price":6.31,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000899243-18-014902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287233/000089924318014902/doc4.xml","form_type":"4"}},{"id":4096592,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported transactions involved an amendment to the post-termination exercise period of outstanding options, resulting in the deemed cancellation of the vested options and the grant of replacement fully vested options."}],"balance_after":10000,"derivative":{"exercise_price":4.4,"exercise_date":"2018-01-16","expiration_date":"2020-07-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096591,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"disposition_to_issuer","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":4.4,"exercise_date":"2018-06-15","expiration_date":"2027-07-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096590,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported transactions involved an amendment to the post-termination exercise period of outstanding options, resulting in the deemed cancellation of the vested options and the grant of replacement fully vested options."}],"balance_after":500,"derivative":{"exercise_price":28.2,"exercise_date":"2018-01-16","expiration_date":"2020-07-11","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096589,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"disposition_to_issuer","acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."}],"balance_after":0,"derivative":{"exercise_price":28.2,"expiration_date":"2026-06-09","underlying":"Common Stock","underlying_shares":500},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096588,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported transactions involved an amendment to the post-termination exercise period of outstanding options, resulting in the deemed cancellation of the vested options and the grant of replacement fully vested options."}],"balance_after":450,"derivative":{"exercise_price":66,"exercise_date":"2018-01-16","expiration_date":"2020-07-11","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096587,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"disposition_to_issuer","acquired":false,"shares":450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."}],"balance_after":0,"derivative":{"exercise_price":66,"expiration_date":"2025-10-22","underlying":"Common Stock","underlying_shares":450},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096586,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported transactions involved an amendment to the post-termination exercise period of outstanding options, resulting in the deemed cancellation of the vested options and the grant of replacement fully vested options."}],"balance_after":550,"derivative":{"exercise_price":66,"exercise_date":"2018-01-16","expiration_date":"2020-07-11","underlying":"Common Stock","underlying_shares":550},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096585,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"disposition_to_issuer","acquired":false,"shares":550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."}],"balance_after":0,"derivative":{"exercise_price":66,"expiration_date":"2025-10-22","underlying":"Common Stock","underlying_shares":550},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096584,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"grant","acquired":true,"shares":197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The reported transactions involved an amendment to the post-termination exercise period of outstanding options, resulting in the deemed cancellation of the vested options and the grant of replacement fully vested options."}],"balance_after":197,"derivative":{"exercise_price":157.2,"exercise_date":"2018-01-16","expiration_date":"2020-07-11","underlying":"Common Stock","underlying_shares":197},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4096583,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-18T23:03:05.000Z","date":"2018-01-16","kind":"disposition_to_issuer","acquired":false,"shares":197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a fifteen-for-one reverse stock split on February 10, 2017."}],"balance_after":0,"derivative":{"exercise_price":157.2,"expiration_date":"2020-05-13","underlying":"Common Stock","underlying_shares":197},"source":{"system":"sec-edgar","filing":"0001209191-18-004356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919118004356/doc4.xml","form_type":"4"}},{"id":4187932,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-10-11T18:56:29.000Z","date":"2017-10-09","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the total number of shares subject to the option shall vest on each of October 9, 2018 and October 9, 2019."}],"balance_after":25000,"derivative":{"exercise_price":9.4,"expiration_date":"2027-10-09","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-17-024062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1287233/000089924317024062/doc4.xml","form_type":"4"}},{"id":4257240,"issuer":{"id":5247,"kind":"organization","name":"GYRE THERAPEUTICS, INC."},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-07-14T20:54:32.000Z","date":"2017-07-13","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest monthly over a period of 12 months commencing June 15, 2017."}],"balance_after":10000,"derivative":{"exercise_price":4.4,"exercise_date":"2018-06-15","expiration_date":"2027-07-13","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-045216","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1124105/000120919117045216/doc4.xml","form_type":"4"}},{"id":4286291,"issuer":{"id":143144,"kind":"organization","name":"PDL BIOPHARMA, INC.","symbol":"PDLI"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2017-06-13T00:20:41.000Z","date":"2017-06-09","kind":"grant","acquired":true,"shares":60729,"price":2.47,"value":150000.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The grant will cliff-vest on the first anniversary of the date of grant so long as the grant recipient continues to serve on the Board of Directors of PDL BioPharma, Inc. During the one-year vesting period, the grant recipient will have the right to vote the shares and receive any dividends and other distributions paid, except that dividends and other distributions will be accumulated and will vest and be paid, with interest, on the earlier of the same vesting conditions as the original award or March 15th of the year following the payment of such dividend or distribution to all stockholders."}],"balance_after":202480,"source":{"system":"sec-edgar","filing":"0000882104-17-000068","document":"wf-form4_149731322578465.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/882104/000088210417000068/wf-form4_149731322578465.xml","form_type":"4"}},{"id":4302847,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-26T21:33:55.000Z","date":"2017-05-25","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest at the earlier on (i) May 25, 2018, or (ii) the date of the 2018 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan)."}],"balance_after":12000,"derivative":{"exercise_price":8.59,"expiration_date":"2027-05-25","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-17-035967","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919117035967/doc4.xml","form_type":"4"}},{"id":4602488,"issuer":{"id":3552,"kind":"organization","name":"Protagonist Therapeutics, Inc","symbol":"PTGX"},"owners":[{"id":55588,"kind":"person","name":"SELICK HAROLD E","position":1,"cik":"0001287233","reported_name":"SELICK HAROLD E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2016-09-15T20:25:11.000Z","date":"2016-09-13","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over a three-year period from the vesting commencement date of August 10, 2016."}],"balance_after":24000,"derivative":{"exercise_price":12.88,"expiration_date":"2026-09-13","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-16-141588","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1377121/000120919116141588/doc4.xml","form_type":"4"}}]}